CHRISTINA KASHMER: Open Payments
NPI 1033827282 · POTSDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 24 payments from 16 companies in 2025. Trend: 2023 $68 · 2024 $45 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Corcept Therapeutics | 2 | $48 |
| Lundbeck LLC | 2 | $40 |
| PFIZER INC. | 1 | $34 |
| AtriCure, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $29 |
| Edwards Lifesciences Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: Fintepla, Kerendia, VERQUVO, Korlym, VYEPTI, VYNDAQEL, ATRICLIP LAA EXCLUSION SYSTEM, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
